Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials

Sag, Alan; Sos, Thomas; Benli, Caghan; Sal, Oğuzhan; Rossignol, Patrick; Ortiz, Alberto; Solak, Yalcin; Kanbay, Mehmet

doi:10.1016/j.jash.2016.02.005

Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials

Atıf İçin Kopyala

Sag A. A., Sos T. A., Benli C., Sal O., Rossignol P., Ortiz A., ...Daha Fazla

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, cilt.10, sa.4, ss.368-377, 2016 (SCI-Expanded)

Yayın Türü: Makale / Derleme
Cilt numarası: 10 Sayı: 4
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.jash.2016.02.005
Dergi Adı: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.368-377
İstanbul Üniversitesi Adresli: Hayır

Özet

Unlike endovascular therapeutic studies for atherosclerosis in many other vascular beds, major trials regarding endovascular renovascular revascularization have resulted in a stagnating equipoise. However, every major trial completed for this topic thus far has suffered from major methodological flaws that limit the validity and external generalizability of their results. Furthermore, certain patient populations who are known to benefit from renovascular revascularization may never be studied because they cannot be ethically withheld from life-saving treatment. Forthcoming percutaneous techniques may one day complement angioplasty and stenting in a burgeoning era of cellular modulation and endovascular-directed renal regeneration. (C) 2016 American Society of Hypertension. All rights reserved.